Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Deferred Revenue (2020 - 2025)

Celularity (CELU) has disclosed Current Deferred Revenue for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 15.99% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 15.99%, while the annual FY2025 figure was $5.3 million, 15.99% down from the prior year.
  • Current Deferred Revenue hit $5.3 million in Q4 2025 for Celularity, down from $5.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $11.9 million in Q1 2021 and bottomed at $2.8 million in Q1 2024.
  • Average Current Deferred Revenue over 5 years is $5.6 million, with a median of $5.0 million recorded in 2023.
  • Year-over-year, Current Deferred Revenue plummeted 72.08% in 2021 and then surged 123.81% in 2025.
  • Celularity's Current Deferred Revenue stood at $4.1 million in 2021, then rose by 10.45% to $4.5 million in 2022, then skyrocketed by 34.02% to $6.0 million in 2023, then rose by 3.9% to $6.3 million in 2024, then decreased by 15.99% to $5.3 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $5.3 million, $5.6 million, and $6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.